CAAS Capital Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-14,518
Closed -$6.75M 608
2021
Q2
$6.75M Buy
+14,518
New +$6.75M 0.11% 67